P3 HEALTH PARTNERS INC (PIII)
US7444131053 - Common Stock
PIII gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 113 industry peers in the Health Care Providers & Services industry. PIII may be in some trouble as it scores bad on both profitability and health. PIII is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
PIII had negative earnings in the past year.
PIII had a negative operating cash flow in the past year.
In the past 5 years PIII always reported negative net income.
PIII had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
With a Return On Assets value of -12.32%, PIII is not doing good in the industry: 72.57% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -85.21%, PIII is doing worse than 76.11% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -12.32% | ||
| ROE | -85.21% | ||
| ROIC | N/A |
ROA(3y)-14.71%
ROA(5y)-27.73%
ROE(3y)-1558.6%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
PIII does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
PIII does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, PIII has more shares outstanding
The debt/assets ratio for PIII is higher compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of -0.16, we must say that PIII is in the distress zone and has some risk of bankruptcy.
PIII's Altman-Z score of -0.16 is on the low side compared to the rest of the industry. PIII is outperformed by 68.14% of its industry peers.
A Debt/Equity ratio of 1.11 is on the high side and indicates that PIII has dependencies on debt financing.
PIII has a worse Debt to Equity ratio (1.11) than 65.49% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.11 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.16 |
ROIC/WACCN/A
WACC6.89%
2.3 Liquidity
PIII has a Current Ratio of 0.53. This is a bad value and indicates that PIII is not financially healthy enough and could expect problems in meeting its short term obligations.
PIII has a Current ratio of 0.53. This is amonst the worse of the industry: PIII underperforms 88.50% of its industry peers.
A Quick Ratio of 0.53 indicates that PIII may have some problems paying its short term obligations.
With a Quick ratio value of 0.53, PIII is not doing good in the industry: 84.96% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.53 | ||
| Quick Ratio | 0.53 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 71.00% over the past year.
The Revenue has grown by 25.37% in the past year. This is a very strong growth!
The Revenue has been growing by 70.57% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-158.33%
Revenue 1Y (TTM)25.37%
Revenue growth 3Y37.65%
Revenue growth 5Y70.57%
Sales Q2Q%25.58%
3.2 Future
PIII is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 30.14% yearly.
PIII is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 19.84% yearly.
EPS Next Y54.88%
EPS Next 2Y29.25%
EPS Next 3Y30.14%
EPS Next 5YN/A
Revenue Next Year24.7%
Revenue Next 2Y19.31%
Revenue Next 3Y19.84%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
PIII reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year PIII is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as PIII's earnings are expected to grow with 30.14% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.25%
EPS Next 3Y30.14%
5. Dividend
5.1 Amount
No dividends for PIII!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
P3 HEALTH PARTNERS INC
NASDAQ:PIII (11/18/2024, 8:00:00 PM)
After market: 0.22 +0.01 (+3.63%)0.2123
-0.02 (-7.09%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap75.94M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -12.32% | ||
| ROE | -85.21% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.77
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.11 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 0.53 | ||
| Quick Ratio | 0.53 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)71%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y54.88%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)25.37%
Revenue growth 3Y37.65%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y